Evaluating Time to In-Hospital Venous Thromboembolism in Obese Patients

被引:0
|
作者
Cutshall, B. Tate [1 ]
Tatara, Alexandra W. [2 ]
Upadhyay, Navneet [3 ]
Adeola, Mobolaji [2 ]
Putney, David [2 ]
Ruegger, Melanie [2 ]
机构
[1] Univ Alabama Birmingham, Dept Pharm, Birmingham Hosp, Birmingham, AL USA
[2] Houston Methodist Hosp, Dept Pharm, Houston, TX 77030 USA
[3] Univ Houston, Coll Pharm, Texas Med Ctr, Dept Pharmaceut Hlth Outcomes & Policy, Houston, TX 77030 USA
关键词
venous thromboembolism; obese; anticoagulation; deep vein thrombosis prophylaxis;
D O I
10.1177/0897190019847002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Currently, no consensus approach exists for optimal venous thromboembolism (VTE) prophylaxis in obese (BMI >= 30 kg/m(2)) patients. Time to development of in-hospital VTE is not well studied. Objective: This study evaluates time to in-hospital VTE in obese patients. Methods: A single-center, retrospective study evaluated obese patients that developed an in-hospital VTE. Patients were categorized into 3 BMI groups: 30 to 34.9 (group 1), 35 to 39.9 (group 2), and >= 40 (group 3) kg/m(2). The primary end point compared time to VTE between the groups. Results: A total of 246 patients were included, and time to VTE was similar between the groups, 8 (group 1) versus 8 (group 2) versus 9 days (group 3); P = .38. Secondary outcomes showed time to VTE was shorter in acute care versus ICU patients (7.5 vs 10 days; P = .01), nonsurgical versus surgical patients (6 vs 9 days; P = .004), and no prophylaxis versus mechanical plus pharmacologic prophylaxis (4.5 vs 9 days; P < .001). Conclusions: BMI category did not significantly impact time to in-hospital VTE. This study provides insight into the timing of in-hospital VTE in obese patients. The differences in prophylactic strategies highlight the importance of optimized prophylaxis.
引用
收藏
页码:190 / 198
页数:9
相关论文
共 50 条
  • [41] High-Dose Venous Thromboembolism Prophylaxis for Obese Patients
    Turco, Neil J.
    PHARMACOTHERAPY, 2016, 36 (11): : E198 - E199
  • [42] Optimal dosing of unfractionated heparin in obese patients with venous thromboembolism
    Khan, SU
    Groth, ML
    Hurewitz, AN
    CHEST, 2005, 128 (04) : 406S - 407S
  • [43] Treatment of Venous Thromboembolism in Patients Who Are Morbidly Obese Reply
    Wilbur, Jason
    Shian, Brian
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (08) : 498 - 498
  • [44] Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism
    Quan, Steven
    Smith, Jenna
    Wu, Cynthia
    Koshman, Sheri L.
    Binh Nguyen
    Bungard, Tammy J.
    THROMBOSIS RESEARCH, 2020, 187 : 56 - 62
  • [45] Unfractionated heparin dosing in obese patients with venous thromboembolism.
    Chu, Chau
    Arnold, Lindsay
    PHARMACOTHERAPY, 2014, 34 (10): : E204 - E204
  • [46] Venous thromboembolism prophylaxis for surgical patients in an Asian hospital
    Tan, LH
    Tan, SC
    ANZ JOURNAL OF SURGERY, 2004, 74 (06) : 455 - 459
  • [47] Venous thromboembolism in patients with autoimmune disorders a small Hospital
    Ruiz Sada, Pablo
    Samperiz Legarre, Angel
    Galbete, Arkaitz
    GALICIA CLINICA, 2021, 82 (04): : 192 - 195
  • [48] The Association Between Time to First Dose of Venous Thromboembolism Prophylaxis and the Incidence of Hospital-Acquired Venous Thromboembolism
    Crossman, Daniel J.
    Liu, Yifan
    Unlu, Ozan
    Steel, Peter
    McCarthy, Matthew
    Zhang, Yiye
    JOURNAL OF PATIENT SAFETY, 2022, 18 (07) : E1034 - E1035
  • [49] Venous thromboembolism in pregnant obese Individuals
    Navti, Osric B.
    Pavord, Sue
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2024, 94
  • [50] Thromboembolism in Patients With Nonalcoholic Steatohepatitis: Baseline Characteristics and In-Hospital Outcomes
    Patel, Kirtenkumar
    Kavani, Himanshu
    Assaassa, Abdalrahman
    Adalja, Devina
    Patel, Krunalkumar
    Tirmizi, Zeeshan
    Patel, Nishi
    Patel, Umang
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S945 - S946